ALISKIREN 300 MG TABLET

aliskiren hemifumarate
$5.5922per EA

Strength

300 mg/1

NDC

66993014230

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ALISKIREN HEMIFUMARATE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021985

On Market Since

3/4/2019

Pharmacological Classes

Renin Inhibitor
Renin Inhibitors

Price History

1W

0.0%

1M

+1.8%

3M

-1.4%

6M

+8.1%

1Y

+2.3%

3Y

-13.5%

5Y

-27.5%

All

-25.1%

Generic Alternatives

1 alternative • Same active ingredient